1. bookVolume 65 (2015): Edizione 4 (December 2015)
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

Preparation and investigation of mefenamic acid – polyethylene glycol – sucrose ester solid dispersions

Pubblicato online: 17 Dec 2015
Volume & Edizione: Volume 65 (2015) - Edizione 4 (December 2015)
Pagine: 453 - 462
Accettato: 14 Jul 2015
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. S. C. Sweetman (Ed.), Martindale: The Complete Drug Reference, 36th ed., Pharmaceutical Press, London 2009, p. 80.Search in Google Scholar

2. M. Batt, Non-coeliac flat jejunal mucosa, Gut 30 (1989) 67-68.10.1136/gut.30.Spec_No.67Search in Google Scholar

3. T. Hamaguchi, D. Shinkuma, Y. Yamanaka and N. Mizuno, Bioavailability of mefenamic acid: influence of food and water intake, J. Pharm. Sci. 75 (1986) 891-893.Search in Google Scholar

4. J. L. Wallace, Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy, World J. Gastroenterol. 19 (2013) 1861-1876; DOI: 10.3748/wjg.v19.i12.1861.10.3748/wjg.v19.i12.1861361310223569332Search in Google Scholar

5. D. V. Derle, M. Bele and N. Kasliwal, In vitro and in vivo evaluation of mefenamic acid and its complexes with b-cyclodextrin and HP-b-cyclodextrin, Asian J. Pharm. 2 (2008) 30-34; DOI: 10. 4103/0973-8398.41562.10.4103/0973-8398.41562Search in Google Scholar

6. G. L. Amidon, H. Lennernas, V. P. Shah and J. R. Crison, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res. 12 (1995) 413-420.Search in Google Scholar

7. D. Mudit, Y. Bhardwaj, P. K. Keshavarao and P. Selvam, Enhancing solubility and dissolution of mefenamic acid by freeze drying using b-cyclodextrin, Int. Res. J. Pharm. 2 (2011) 146-150; DOI: http://dx.doi.org/10.1590/S1984-82502011000400011.10.1590/S1984-82502011000400011Search in Google Scholar

8. U. Domanska, A. Pelczara and A. Pobudowska, Effect of 2-hydroxypropyl-b-cyclodextrin on solubility of sparingly soluble drug derivatives of anthranilic acid, Int. J. Mol. Sci. 12 (2011) 2383-2394; DOI: 10.3390/ijms12042383.10.3390/ijms12042383312712321731447Search in Google Scholar

9. I. Fülöp, Á. Gyéresi and Ș. Hobai, Characterisation of the interaction between fenamates and hydroxy- propyl-b-cyclodextrin, Bull. Med. Sci. 83 (2010) 58-62.Search in Google Scholar

10. K. R. Rao, M. V. Nagabhushanam and K. P. Chowdary, In vitro dissolution studies on solid dispersions of mefenamic acid, Indian J. Pharm. Sci. 73 (2011) 243-247; DOI: 10.4103/0250-474X.91575.10.4103/0250-474X.91575Search in Google Scholar

11. G. Owusu-Ababio, N. K. Ebube, R. Reams and M. Habib, Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets, Pharm. Dev. Technol. 3 (1998) 405-412; DOI: 10.3109/10837459809009868.10.3109/108374598090098689742561Search in Google Scholar

12. A. Dahan A and J. M. Miller, The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs, AAPS J. 14 (2012) 244-251; DOI: 10.1208/ s12248-012-9337-6. 10.1208/s12248-012-9337-6332616022391790Search in Google Scholar

13. A. Beig, R. Agbaria and A. Dahan, Oral delivery of lipophilic drugs: The tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations, Plos One 8 (2013) e68237; DOI: 10.1371/journal.pone.0068237.10.1371/journal.pone.0068237371297023874557Search in Google Scholar

14. G. E. Amidon, W. I. Higuchi and N. F. Ho, Theoretical and experimental studies of transport of micelle-solubilized solutes, J. Pharm. Sci. 71 (1982) 77-84.10.1002/jps.26007101207057387Search in Google Scholar

15. J. M. Miller, A. Beig, R. A. Carr, G. K. Webster and A. Dahan, The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations, Mol. Pharm. 9 (2012) 581-590; DOI: 10.1021/mp200460u.10.1021/mp200460uSearch in Google Scholar

16. A. Beiq, J. M. Miller and A. Dahan, Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption, Eur. J. Pharm. Biopharm. 81 (2012) 386-391; DOI: 10.1016/j.ejpb.2012.02.012.10.1016/j.ejpb.2012.02.012Search in Google Scholar

17. L. Kiss, E. Hellinger, A. M. Pilbat, A. Kittel, Z. Török, A. Füredi, G. Szakács, S. Veszelka, P. Sipos, B. Ózsvári, L. G. Puskás, M. Vastag, P. Szabó-Révész and M. A. Deli, Sucrose esters increase drug penetration, but do not inhibit P-glycoprotein in Caco-2 intestinal epithelial cells, J. Pharm. Sci. 103 (2014) 3107-3119; DOI: 10.1002/jps.24085.10.1002/jps.24085Search in Google Scholar

18. A. Szűts and P. Szabó-Révész, Sucrose esters as natural surfactants in drug delivery systems - a mini-review, Int. J. Pharm. 433 (2012) 1-9; DOI: 10.1016/j.ijpharm.2012.04.076.10.1016/j.ijpharm.2012.04.076Search in Google Scholar

19. T. Hladon, J. Pawlaczyk and B. Szafran, Stability of mefenamic acid in the inclusion complex with b-cyclodextrin in the solid phase, J. Incl. Phenom. Macrocycl. Chem. 35 (1999) 497-506; DOI: 10.1023/ A:1008048612736.10.1023/A:1008048612736Search in Google Scholar

20. Ryoto Sugar Ester Technical Information, Ryoto Sugar Ester (Food grade)/ Surfhope™ SE Pharma, Mitsubishi-Kagaku Foods Corporation; http://www.mfc.co.jp/english; last access date May 25, 2015.Search in Google Scholar

21. A. Szűts, E. Pallagi, G. Regdon, Jr., Z. Aigner and P. Szabó-Révész, Study of thermal behaviour of sugar esters, Int. J. Pharm. 336 (2007) 199-207; DOI: 10.1016/j.ijpharm.2006.11.053.10.1016/j.ijpharm.2006.11.053Search in Google Scholar

22. A. Szűts, Zs. Makai, R. Rajkó and P. Szabó-Révész, Study of the effects of drugs on the structures of sucrose esters and the effects of solid-state interactions on drug release, J. Pharm. Biomed. Anal. 48 (2008) 1136-1142; DOI: 10.1016/j.jpba.2008.08.028.10.1016/j.jpba.2008.08.028Search in Google Scholar

23. European Pharmacopoeia 8th ed., Council of Europe, Strasbourg 2013, pp. 288-295.Search in Google Scholar

24. Y. Zhang, M. Huo, J. Zhou, A. Zou, W. Li, C. Yao and S. Xie, DDSolver: an add-in program for modeling and comparison of drug dissolution profiles, AAPS J. 12 (2010) 263-271; DOI: 10.1208/ s12248-010-9185-1.Search in Google Scholar

25. P. Costa and J. M. Sousa Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1Search in Google Scholar

26. I. Fülöp, Á. Gyéresi, M. A. Deli, L. Kiss, M. D. Croitoru, P. Szabó-Révész and Z. Aigner, Ternary solid dispersions of oxicams: Dissolution and permeability study, Farmacia 63 (2015) 286-295.Search in Google Scholar

27. M. Dixit, A. Kini and P. K. Kulkarni, Enhancing the dissolution of polymorphs I and II of mefenamic acid by spray drying, Turk. J. Pharm. Sci. 9 (2012) 13-26.Search in Google Scholar

28. S. Romero, B. Escalera and P. Bustamante, Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures, Int. J. Pharm. 178 (1999) 193-202.10.1016/S0378-5173(98)00375-5Search in Google Scholar

29. S. G. Vijaya Kumar and D. N. Mishra, Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000, Yakugaku Zasshi (J. Pharm. Sci. Japan) 126 (2006) 657-664.10.1248/yakushi.126.65716880724Search in Google Scholar

30. H. Lokhandwala, A. Deshpande and S. Deshpande, Kinetic modelling and dissolution profiles comparison: an overview, Int. J. Pharm. Biol. Sci. 4 (2013) 728-737. Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo